Sumitomo Life Insurance’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$647K Buy
13,194
+550
+4% +$25.6K 0.02% 238
2025
Q4
$551K Sell
12,644
-10
-0.1% -$456 0.02% 249
2025
Q3
$570K Sell
12,654
-521
-4% -$22.9K 0.02% 234
2025
Q2
$572K Sell
13,175
-698
-5% -$31.1K 0.04% 231
2025
Q1
$639K Buy
13,873
+186
+1% +$7.78K 0.02% 228
2024
Q4
$515K Sell
13,687
-529
-4% -$20.5K 0.01% 244
2024
Q3
$576K Buy
14,216
+145
+1% +$5.45K 0.01% 244
2024
Q2
$487K Sell
14,071
-1,956
-12% -$72.2K 0.01% 247
2024
Q1
$602K Sell
16,027
-894
-5% -$31.9K 0.02% 237
2023
Q4
$607K Sell
16,921
-80
-0.5% -$3.08K 0.02% 231
2023
Q3
$642K Sell
17,001
-538
-3% -$21.9K 0.02% 220
2023
Q2
$715K Sell
17,539
-1,806
-9% -$74.7K 0.03% 219
2023
Q1
$810K Sell
19,345
-198
-1% -$8.25K 0.07% 205
2022
Q4
$845K Sell
19,543
-163
-0.8% -$6.44K 0.06% 201
2022
Q3
$738K Sell
19,706
-2,083
-10% -$92.1K 0.03% 211
2022
Q2
$987K Buy
21,789
+24
+0.1% +$1.13K 0.03% 192
2022
Q1
$1.04M Sell
21,765
-9,034
-29% -$383K 0.03% 201
2021
Q4
$1.27M Sell
30,799
-1,070
-3% -$40.3K 0.03% 187
2021
Q3
$1.1M Sell
31,869
-1,440
-4% -$49.2K 0.03% 199
2021
Q2
$1.05M Sell
33,309
-4,797
-13% -$154K 0.03% 214
2021
Q1
$1.19M Sell
38,106
-1,573
-4% -$47.3K 0.05% 210
2020
Q4
$1.2M Sell
39,679
-4,825
-11% -$142K 0.05% 204
2020
Q3
$1.14M Sell
44,504
-3,296
-7% -$87.4K 0.05% 198
2020
Q2
$1.24M Sell
47,800
-3,001
-6% -$79.7K 0.07% 183
2020
Q1
$1.33M Buy
50,801
+496
+1% +$15.6K 0.09% 150
2019
Q4
$1.64M Buy
50,305
+2,996
+6% +$97K 0.19% 165
2019
Q3
$1.63M Sell
47,309
-5,820
-11% -$195K 0.21% 144
2019
Q2
$1.82M Buy
53,129
+16,869
+47% +$595K 0.21% 137
2019
Q1
$1.3M Sell
36,260
-3,996
-10% -$136K 0.17% 184
2018
Q4
$1.29M Buy
40,256
+986
+3% +$31.5K 0.18% 175
2018
Q3
$1.22M Sell
39,270
-822
-2% -$25.3K 0.15% 212
2018
Q2
$1.22M Buy
40,092
+1,732
+5% +$49.6K 0.15% 208
2018
Q1
$1.07M Sell
38,360
-1,804
-4% -$48.7K 0.14% 219
2017
Q4
$1.13M Sell
40,164
-1,810
-4% -$52K 0.14% 223
2017
Q3
$1.13M Sell
41,974
-760
-2% -$20.3K 0.14% 216
2017
Q2
$1.1M Buy
42,734
+1,801
+4% +$45.8K 0.14% 218
2017
Q1
$1.05M Sell
40,933
-2,540
-6% -$64.7K 0.15% 212
2016
Q4
$1.1M Buy
43,473
+966
+2% +$22.9K 0.16% 212
2016
Q3
$1.01M Sell
42,507
-5,155
-11% -$130K 0.15% 220
2016
Q2
$1.24M Sell
47,662
-1,623
-3% -$40.1K 0.17% 203
2016
Q1
$1.26M Sell
49,285
-1,493
-3% -$33.4K 0.16% 200
2015
Q4
$1.01M Sell
50,778
-1,196
-2% -$24.2K 0.13% 225
2015
Q3
$1.1M Sell
51,974
-1,324
-2% -$29.8K 0.15% 227
2015
Q2
$1.19M Sell
53,298
-6,595
-11% -$158K 0.15% 226
2015
Q1
$1.44M Sell
59,893
-6,342
-10% -$157K 0.16% 215
2014
Q4
$1.75M Sell
66,235
-3,697
-5% -$94.9K 0.17% 211
2014
Q3
$1.7M Sell
69,932
-1,877
-3% -$44K 0.17% 222
2014
Q2
$1.87M Buy
71,809
+376
+0.5% +$9.59K 0.18% 210
2014
Q1
$1.71M Sell
71,433
-5,921
-8% -$125K 0.17% 213
2013
Q4
$1.51M Sell
77,354
-4,404
-5% -$88.6K 0.14% 227
2013
Q3
$1.73M Sell
81,758
-2,738
-3% -$59.9K 0.16% 216
2013
Q2
$1.86M Buy
+84,496
New +$2.05M 0.18% 208

Other funds holding EXC

Sumitomo Life Insurance's EXC Position: Q1 2026 in Review

Sumitomo Life Insurance increased its Exelon (EXC) stake by 4.3% in Q1 2026, buying an estimated $25.6K and bringing the position to 13,194 shares worth $647K. The position accounts for 0.02% of the portfolio, ranked #238.

Sumitomo Life Insurance first reported a position in EXC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.87M in Q2 2014. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Sumitomo Life Insurance held 13,194 shares of Exelon worth $647K as of Q1 2026.
  • Sumitomo Life Insurance bought 550 Exelon shares in Q1 2026, an estimated $25.6K.
  • Exelon made up 0.02% of Sumitomo Life Insurance's portfolio in Q1 2026, its #238 holding.
  • Sumitomo Life Insurance first reported a position in Exelon in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Life Insurance's Exelon position peaked at $1.87M in Q2 2014.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.